Organisation paid for research Program year 2025 Source: CMS Open Payments

Chemidox

Neither a doctor nor a teaching hospital

Research payments

$188,373

13 payments

Through program year 2025, Chemidox is reported as receiving $188,373 in research payments, across 13 payments.

By program year

2 rows
Year Kind Amount Payments
2025 Research $142,873 11
2024 Research $45,500 2

Breakdown

Who paid Research payments · program years 2024–2025
  1. AstraZeneca Pharmaceuticals LP $126,892 2 payments
  2. E.R. Squibb & Sons, L.L.C. $45,500 2 payments
  3. GlaxoSmithKline, LLC. $13,848 8 payments
  4. Pfizer Inc. $2,133 1 payment
Studies the money was for Research payments · program years 2024–2025
  1. A Phase III Randomised Double Blind PlaceboControlled Parallel Group Study to Assess the Effect of AZD0780 on Low Density Lipoprotein Cholesterol in Patients With Elevated Low Density Lipoprotein Cholesterol and Clinical Atherosclerotic Cardiovascular Disease or at Risk for a First Atherosclerotic Cardiovascular Disease Event $90,997 1 payment
  2. A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event $35,895 1 payment
  3. Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects with Psychosis Associated with Alzheimers Disease Dementia $23,000 1 payment
  4. A Phase 3, Randomized, Double-blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimers Disease Dementia $22,500 1 payment
  5. A Phase 2, Randomized, Double-Blind, Multi-Dose, Dose Finding Study to $13,848 8 payments
  6. A Phase 3 Randomized Placebocontrolled Doubleblinded Trial to Evaluate the Safety Tolerability and Immunogenicity of A Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants $2,133 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record